Metagenomi, Inc. Common Stock (MGX) SEC Filings: History & Chart

Metagenomi, Inc. Common Stock(MGX)

Biotechnology · Emeryville, CA

$1.07+0.02 (+2.40%)

Delayed quote: Oct 6, 2026, 1:09 PM EDT

About Metagenomi, Inc. Common Stock

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

Emeryville, CA

113 employees

www.metagenomi.co

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jian Irish

View full financials

Form	Filing Date	Accepted	Document
8-K	Sep 22, 2026	Sep 21, 2026	View filing
4	Sep 11, 2026	Sep 11, 2026	View filing
SC 13G	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 10, 2026	Sep 10, 2026	View filing
10-Q	Aug 10, 2026	Aug 10, 2026	View filing
8-K	Aug 10, 2026	Aug 10, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 10, 2026	Jun 10, 2026	View filing
4	Jun 10, 2026	Jun 10, 2026	View filing
4	Jun 10, 2026	Jun 10, 2026	View filing
8-K	Jun 10, 2026	Jun 9, 2026	View filing
10-Q	May 11, 2026	May 11, 2026	View filing
8-K	May 11, 2026	May 11, 2026	View filing
ARS	Apr 27, 2026	Apr 27, 2026	View filing
DEFA14A	Apr 27, 2026	Apr 27, 2026	View filing
DEF 14A	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 3, 2026	Apr 3, 2026	View filing
4	Apr 3, 2026	Apr 3, 2026	View filing
4	Apr 3, 2026	Apr 3, 2026	View filing
4	Mar 9, 2026	Mar 9, 2026	View filing
4	Mar 9, 2026	Mar 9, 2026	View filing
4	Mar 9, 2026	Mar 9, 2026	View filing
S-8	Mar 5, 2026	Mar 5, 2026	View filing
10-K	Mar 5, 2026	Mar 5, 2026	View filing
8-K	Mar 5, 2026	Mar 5, 2026	View filing

SEC Filings

Recent Filings